Akèy › Maladi Crohn › Kentucky › Louisville
Etid klinik pou Maladi Crohn nan Louisville, KY
9 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Louisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- Gastroenterology Health Partners /ID# 284144, Louisville
- Gastroenterology Health Partners /ID# 284145, New Albany · 4 mi lwen
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- University of Louisville Hospital ( Site 5120), Louisville
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- University Of Louisville, Louisville
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- University of Louisville - MedCenter One, Louisville
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Gastroenterology Health Partners, Louisville
- Gastroenterology Health Partners, New Albany · 4 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi lwen
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi lwen
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- University of Louisville, Louisville
Treatment of Moderate to Severe Refractory Crohn's Disease
Ap rekriteFaz 1/2
- University of Louisville, Louisville
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Los Angeles, CA15 etid
Lòt etid nan Louisville
- Kansè Poumon ki pa ti selil22 etid
- Obèsite17 etid
- Sipwa15 etid
- Kansè (tout kalite)14 etid
- Ensifizyans kadyak13 etid
- Leksemi mieloïd egi12 etid
- Myelom Miltip12 etid
- Kansè ovè12 etid
- Kansè nan tete11 etid
- Karsinòm selil skuamèz tèt ak kou11 etid
- Kansè poumon11 etid
- Melanom10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.